Nevro Net Profit Margin from 2010 to 2024
| NVRO Stock | USD 3.97 0.20 5.31% |
Check Nevro Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nevro Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nevro financial statements analysis is a perfect complement when working with Nevro Corp Valuation or Volatility modules.
Nevro |
About Nevro Corp Financial Statements
Nevro Corp investors utilize fundamental indicators, such as Net Profit Margin, to predict how Nevro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. Nevro Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 945 people.
Pair Trading with Nevro Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.Moving against Nevro Stock
| 0.69 | VVOS | Vivos Therapeutics Downward Rally | PairCorr |
| 0.63 | DXCM | DexCom Inc | PairCorr |
| 0.62 | EW | Edwards Lifesciences Corp | PairCorr |
| 0.61 | OM | Outset Medical | PairCorr |
| 0.59 | GH | Guardant Health | PairCorr |
The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.
The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Nevro Corp Correlation against competitors. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.